Massive transfusion (MT) is defined as transfusion of at least 10 U of red blood cells (RBCs) within a 24-hour period, although alternate definitions, such as 3 U/h (critical administration threshold), are also used to more accurately reflect most transfusions that occur in the first 6 hours.
1 In addition to RBCs, fresh frozen plasma (FFP) and platelets may be transfused as a ratio of RBCs in an approach termed
balanced resuscitation. For example, transfusing 1 U of FFP for every 2 U of RBCs is a 1:2 strategy. Although ratio-based resuscitation is not a new concept,
2 interest was rekindled in the past decade when retrospective studies from the US military reported improved survival when massively transfused injured soldiers received resuscitation with higher (compared with lower) amounts of FFP to RBCs (FFP:RBC ratio).
3 Additional reports from civilian trauma centers supported these findings, and the practice of transfusing higher FFP:RBC ratios was quickly embraced by the trauma surgery and anesthesia community, with many hospitals implementing formal massive transfusion protocols (MTPs) with high FFP:RBC ratios.
4,5 Until recently, high-quality evidence supporting this practice had been lacking. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study described transfusion ratios and clinical outcomes in a prospective observational manner and concluded that higher ratios of FFP and platelets administered early in resuscitation were associated with decreased mortality in the first 24 hours.
6 Quiz Ref ID However, the subsequent Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial found no difference in 24-hour or 30-day survival outcomes when comparing a 1:1:1 (FFP to platelets to RBCs) resuscitation strategy with a 1:1:2 strategy.
7 While it is now common practice for trauma patients who require MT to receive ratio-based resuscitation, the exact ratio continues to be explored.